Based on cancer genomic databases, we found that ZNF768 overexpression is common in a variety of human cancers suggesting that elevated levels of ZNF768 could serve as a way to bypass oncogene-induced senescence and sustain tumor proliferation. Here, ZNF768 is linked to cancer.